IDEA Regulatory

Bronze Sponsor

IDEA specialises in providing pharmaceutical and biotech developers with Regulatory Affairs and EU legal representation for clinical trials and orphan drug designations (ODD). We offer a range of Regulatory Affairs services to help our clients understand and comply with clinical trial regulations and help ensure a smooth path to Marketing Authorisation Approval.

Our clients include:

  • Niche (orphan) drug developers looking to gain ODD in the USA and Europe
  • Clinicians looking to ensure trial data is valid and appropriately covered
  • Investors seeking to maximize the market opportunity of new molecules
  • CRO’s who know the importance of determining suitable liability and trial subject insurance to cover human trials in Europe.

IDEA’s expert regulatory services range from the provision of stand-alone representative services for an Orphan Drug Designation (ODD) to the design and implementation of a full global regulatory and market access strategy. We are experts at the preparation and review of Regulatory Submissions, including Clinical Trial Authorisation applications and substantial amendments, Orphan Drug Designation applications to the EMA, and parallel submissions to the US FDA, Briefing Packages for Scientific Advice Procedures, Paediatric Investigation Plan (PIP) Applications and Waivers, and Annual Regulatory Reports.



website

Get Involved At World Orphan Drug Congress 2018

 

To Sponsor Or Exhibit

 
 

Andrew Mears
andrew.mears@terrapinn.com
t/ +44 20 7092 1228

 

 

 

To Speak

 
 

Wing-Yun Cheung
wing-yun.cheung@terrapinn.com
t/ +44 20 7092 1172

 

 

 

To Register

 
 

Issa Mauthoor
issa.mauthoor@terrapinn.com
t/ +44 20 7092 1257